Philippe Bernard

Maréchal Koenig Avenue
Reims, 51092, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Clustered spiradenomas associated with ALPK1 mutation.

Clustered spiradenomas associated with ALPK1 mutation.

Journal: European journal of dermatology : EJD

Published: March 23, 2026

Combined methotrexate and short-term superpotent topical corticosteroids compared with prolonged superpotent topical corticosteroids alone in bullous pemphigoid: a multicentre, noninferiority randomised clinical trial.

Combined methotrexate and short-term superpotent topical corticosteroids compared with prolonged superpotent topical corticosteroids alone in bullous pemphigoid: a multicentre, noninferiority randomised clinical trial.

Journal: The British journal of dermatology

Published: December 02, 2025

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Specific serum and skin immunological profiles of patients with bullous pemphigoid requiring biologics.

Specific serum and skin immunological profiles of patients with bullous pemphigoid requiring biologics.

Journal: The British journal of dermatology

Published: May 29, 2025

Combination of Omalizumab and Dupilumab for the Treatment of Severe Bullous Pemphigoid: a Series of 6 Cases.

Combination of Omalizumab and Dupilumab for the Treatment of Severe Bullous Pemphigoid: a Series of 6 Cases.

Journal: Acta dermato-venereologica

Published: April 15, 2025

Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris.

Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris.

Journal: JAMA dermatology

Published: March 05, 2025

Severe verrucous erythema elevatum diutinum responding to a combined therapy with low-dose dapsone and prednisone.

Severe verrucous erythema elevatum diutinum responding to a combined therapy with low-dose dapsone and prednisone.

Journal: Clinical and experimental dermatology

Published: October 17, 2024

Invasive Cuniculatum Carcinoma of the Groin Mimicking Hidradenitis Suppurativa.

Invasive Cuniculatum Carcinoma of the Groin Mimicking Hidradenitis Suppurativa.

Journal: The American Journal of dermatopathology

Published: September 17, 2024

Management of Melanoma in Elderly Patients over 80 Years.

Management of Melanoma in Elderly Patients over 80 Years.

Journal: Acta dermato-venereologica

Published: June 20, 2024

Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.

Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.

Journal: JAMA dermatology

Published: January 24, 2024

The functional disabilities of the dominant and opposite hands in patients with systemic sclerosis.

The functional disabilities of the dominant and opposite hands in patients with systemic sclerosis.

Journal: Clinical and experimental rheumatology

Published: October 19, 2023

Showing 1-12 of 78

Last Updated: 09/26/2026